Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące rozpoznawania i leczenia zaburzeń oddychania w czasie snu (ZOCS) u dorosłych

Pneumonologia i Alergologia Polska

Volumn 81, Issue 3, 2013, Pages 221-258

  Pływaczewski, Robert ^a   Brzecka, Anna ^a   Bielicki, Piotr ^a   Czajkowska Malinowska, Małgorzata ^a   Cofta, Szczepan ^a   Jonczak, Luiza ^a   Radliński, Jakub ^a   Tazbirek, Maciej ^a   Wasilewska, Jolanta ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN INFARCTION; CLASSIFICATION; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERTENSION; NOTE; OBESITY; PATHOPHYSIOLOGY; POLAND; POLYSOMNOGRAPHY; PRACTICE GUIDELINE; PULMONARY HYPERTENSION; RESPIRATORY TRACT MALFORMATION; RISK FACTOR; SLEEP DISORDERED BREATHING; SMOKING; SURVIVAL RATE;

CEREBRAL INFARCTION; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTENSION; HYPERTENSION, PULMONARY; OBESITY; POLAND; POLYSOMNOGRAPHY; RESPIRATORY SYSTEM ABNORMALITIES; RISK FACTORS; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE; SMOKING; SURVIVAL RATE;

EID: 84876480128     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (239)

1. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed. Diagnostic and coding manual. Westchester, Illinois: American Academy of Sleep Medicine 2005.
2. American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research: the report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
3. Lavie P., Herer P., Peled R. i wsp. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18: 149-157.
4. Marti S., Sampol G., Munoz X. i wsp. Mortality in severe sleep apnoea/hypopnoea syndrome patients; impact of treatment. Eur. Respir. J. 2002; 20: 1511-1518.
5. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 1993; 328: 1230-1235.
6. Bearpark H., Elliott L., Grunstein R. i wsp. Snoring and sleep apnea. A population study in Australian men. Am. J. Respir. Crit. Care Med. 1995; 151: 1459-1465.
7. Gislason T., Almqvist M., Eriksson G., Taube A., Boman G. Prevalence of sleep apnea syndrome among Swedish men - an epidemiological study. J. Clin. Epidemiol. 1988; 41: 571-576.
8. Kripke D.F., Ancoli-Israel S., Klauber M.R., Wingard D.L., Mason W.J., Mullaney D.J. Prevalence of sleep-disordered breathing in ages 40-64 years: a population-based survey. Sleep 1997; 20: 65-76.
9. Bixler E.O., Vgontzas A.N., Ten Have T., Tyson K., Kales A. Effects of age on sleep apnea in men. Am. J. Respir. Crit. Care Med. 1998; 157: 144-148.
10. Bixler E.O., Vgontzas A.N., Lin H.M., Ten Have T., Rein J., Vela-Bueno A., Kales A. Prevalence of sleep-disordered breathing in women. Am. J. Respir. Crit. Care Med. 2001; 163: 608-613.
11. Duran J., Esnaola S., Rubio R., Iztueta A. Obstructive sleep apnea- hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am. J. Respir. Crit. Care Med. 2001; 163: 685-689.
12. Stradling J.R., Crosby J.H. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991; 46: 85-90.
13. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea. A population health perspective. Am. J. Respir. Crit. Care Med. 2002; 165: 1217-1239.
14. Stohl K., Redline S. Recognition of obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 1996; 154: 274-289.
15. Duran C.J. Prevalence of obstructive sleep apnea-hypopnea and related clinical features in the elderly: a population-based study in general population aged 71-100. World Conference 2001 Sleep Odyssey, October 21-26, 2001, Montevideo, Uruguay.
16. Young T., Shahar E., Nieto J. i wsp.; for the Sleep Heart Study Research Group. Predictors of sleep-disordered breathing in community- dwelling adults. Arch. Intern. Med. 2002; 162: 893-900.
17. Pływaczewski R., Bednarek M., Jonczak L., Zieliński J. Sleepdisordered breathing in a middle-aged and older Polish urban population. J. Sleep Res. 2008; 17: 73-81.
18. Schwab R.J., Gupta K.B., Gefter W.B., Hoffman E.A., Pack A.I. Upper airway soft tissue anatomy in normals and patients with sleep disordered breathing. Significance of the lateral pharyngeal walls. Am. J. Respir. Crit. Care Med. 1995; 152: 1673-1689.
19. Schwab R.J., Gefter W.B., Hoffman E.A., Gupta K.B., Pack A.I. Dynamic upper airway imaging during respiration in normal subjects and patients with sleep disordered breathing. Am. Rev. Respir. Dis. 1993; 148: 1385-1400.
20. Schwab R.J., Goldberg A.N. Upper airway assessment - radiographic and other imaging techniques. Otolaryngol. Clin. North Am. 1998; 3: 931-968.
21. Shepard J.W. Jr., Thawley S.E. Evaluation of the upper airway by computerized tomography in patients undergoing uvulopalatopharyngoplasty for obstructive sleep apnea. Am. Rev. Respir. Dis. 1989; 140: 711-716.
22. Horner R.L., Shea S.A., McIvor J., Guz A. Pharyngeal size and shape during wakefulness and sleep in patients with obstructive sleep apnoea. Q. J. Med. 1989; 72: 719-735.
23. Shelton K.E., Gay S.B., Woodson H., Surratt P.M. Pharyngeal fat in obstructive sleep apnea. Am. Rev. Respir. Dis. 1993; 148: 462-466.
24. Bacon W.H., Turlot J.C., Krieger J., Stierle J.-L. Cephalometric evaluation of pharyngeal obstructive factors in patients with sleep apnea syndrome. Angle Orthod. 1990; 60: 115-122.
25. DeBerry-Borowiecki B., Kukwa A., Blanks R.H. Cephalometric analysis for diagnosis and treatment of obstructive sleep apnea. Laryngoscope 1988; 98: 226-234.
26. Lowe A.A., Fleetham J.A., Adachi S., Ryan C.F. Cephalometric and computed tomographic predictors of obstructive sleep apnea severity. Am. J. Orthod. Dentofac. Orthoped. 1995; 107: 589-595.
27. Lyberg T., Krogstad O., Djupesland G. Cephalometric analysis in patients with obstructive sleep apnoea syndrome. Skeletal morphology. J. Laryngol. Otol. 1989; 103: 287-292.
28. Lyberg T., Krogstad O., Djupesland G. Cephalometric analysis in patients with obstructive sleep apnoea syndrome: II. Soft tissue morphology. J. Laryngol. Otol. 1989; 103: 293-297.
29. Pracharktam N., Hans M.G., Strohl K.P., Redline S. Upright and supine cephalometric evaluation of obstructive sleep apnea syndrome and snoring subjects. Angle Orthod. 1994; 64: 63-73.
30. Goldberg A.N., Schwab R.J. Identifying the patient with sleep apnea: upper airway assessment and physical examination. Otolaryngol. Clin. North Am. 1998; 31: 919-930.
31. Ryan C.F., Lowe A.A., Li D., Fleetham J.A. Three-dimensional upper airway computed tomography in obstructive sleep apnea. Am. Rev. Respir. Dis. 1991; 144: 428-432.
32. Rodenstein D.O., Dooms G., Thomas Y. i wsp. Pharyngeal shape and dimensions in healthy subjects, snorers, and patients with obstructive sleep apnoea. Thorax 1990; 45: 722-727.
33. Leiter J.C. Upper airway shape: is it important in the pathogenesis of obstructive sleep apnea? Am. J. Respir. Crit. Care Med. 1996; 153: 894-898.
34. White D.P. Sleep-related breathing disorder. Pathophysiology of obstructive sleep apnoea. Thorax 1995; 50: 797-804.
35. Neill A.M., Angus S.M., Sajkov D. i wsp. Effects of sleep posture on upper airway stability in patients with obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 1997; 155: 199-204.
36. Matsuzawa Y., Hayashi S., Yamaguchi S. i wsp. Effect of prone position on apnea severity in obstructive sleep apnea. Ann. Intern. Med. 1995; 34: 1190-1193.
37. Pevernagie D.A., Stanson A.W., Sheedy P.F. 2nd i wsp. Effects of body position on the upper airway of patients with obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 1995; 152: 179-185.
38. Wasicko M.J., Hatt D.A., Parisi R.A. i wsp. The role of vascular tone in the control of upper airway collapsibility. Am. Rev. Respir. Dis. 1990; 141: 1569-1577.
39. Phillipson E.A., Sullivan C.E., Read D.J.C. i wsp. Ventilatory and waking responses to hypoxia in sleeping dogs. J. Appl. Physiol. 1978; 44: 512-520.
40. Phillipson E.A., Kozar L.F., Rebuck A.S., Murphy E. Ventilatory and waking responses to CO2 in sleeping dogs. Am. Rev. Respir. Dis. 1977; 115: 1251-1259.
41. Olson L.G., Hensley M.J., Saunders N.A. Effect of slow wave sleep on the ventilatory responses to hypoxia in healthy subjects. Proc. Aust. Physiol. Pharmacol. Soc. 1981; 12: 219 P.
42. Yosuma F., Kozar L.F., Kimoff R.J., Bradley T.D., Phillipson E.A. Interaction of chemical and mechanical respiratory stimuli in the arousal response to hypoxia in sleeping dogs. Am. Rev. Respir. Dis. 1991; 143: 1274-1277.
43. Gleeson K., Zwillich C.W., White D.P. The influence of increasing ventilatory effort on arousal from sleep. Am. Rev. Respir. Dis. 1990; 142: 295-300.
44. Gugger M., Bögershansen S., Schäffler I. Arousal responses to added inspiratory resistance durimg REM and non-REM sleep in normal subjects. Thorax 1993; 48: 125-129.
45. Sullivan C.E., Issa F.G. Pathophysiological mechanisms in obstructive sleep apnea. Sleep 1980; 3: 235-246.
46. Findley L.J., Wilhoit S.C., Suratt P.M. Apnea duration and hypoxemia during REM sleep in patients with obstructive sleep apnea. Chest 1985; 87: 432-436.
47. Zieliński J., Pływaczewski R., Bednarek M. Zaburzenia oddychania w czasie snu. PZWL, Warszawa 2006.
48. Pływaczewski R. Obturacyjny bezdech podczas snu. W: Antaczak A., Myśliwiec M., Pruszczyk P. (red.). Pulmonologia. Tom II; Wielka Interna, Warszawa, Medical Tribune Polska 2010; 21-32.
49. Lurie A. Obstructive sleep apnea in adults: epidemiology, clinical presentation, and treatment options. Adv. Cardiol. 2011; 46: 1-42.
50. Madani M., Madani F. Epidemiology, pathophysiology, and clinical features of obstructive sleep apnea. Oral Maxillofac. Surg. Clin. North Am. 2009; 21: 369-75.
51. Schlosshan D., Elliott M.W. Sleep. 3: Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome. Thorax 2004; 59: 347-352.
52. Skomro R.P., Kryger M.H. Clinical presentations of obstructive sleep apnea syndrome. Prog. Cardiovas.c Dis. 1999; 41: 331-340.
53. Resta O., Foschino-Barbaro M.P., Legari G. i wsp. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int. J. Obes. Relat. Metab. Disord. 2001; 25: 669-675.
54. Johns M.W. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-545.
55. Johns M.W. Reliability and factor analysis of the Epworth Sleepness Scale. Sleep 1992; 15: 376-381.
56. Johns M.W. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993; 103: 30-36.
57. Isono S. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirology 2012; 17: 32-42.
58. Lam J.C., Mak J.C., Ip M.S. Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology 2012;17: 223-36.
59. Bonsignore M.R., McNicholas W.T., Montserrat J.M., Eckel J. Adipose tissue in obesity and obstructive sleep apnoea. Eur. Respir. J. 2012; 39: 746-767.
60. Romero-Corral A., Caples S.M., Lopez-Jimenez F., Somers V.K. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest 2010; 137: 711-719.
61. Shah N., Roux F. The relationship of obesity and obstructive sleep apnea. Clin. Chest Med. 2009; 30: 455-465.
62. Crummy F., Piper A.J., Naughton M.T. Obesity and the lung: 2. Obesity and sleep-disordered breathing. Thorax 2008; 63: 738-746.
63. Flemons W.W., Whitelaw W.A., Brant R., Remmers J.E. Likelihood ratios for a sleep apnea clinical prediction rule. Am. J. Respir. Crit. Care Med. 1994;150: 1279-1285.
64. Flemons W.W., McNicholas W.T. Clinical prediction of the sleep apnea syndrome. Sleep Med. Rev. 1997; 1: 19-32.
65. Flemons W.W. Clinical practice. Obstructive sleep apnea. N. Engl. J. Med. 2002; 347: 498-504.
66. Sutherland K., Lee R.W., Cistulli P.A. Obesity and craniofacial structure as risk factors for obstructive sleep apnoea: impact of ethnicity. Respirology 2012; 17: 213-22.
67. Sakakibara H., Tong M., Matsushita K., Hirata M., Konishi Y., Suetsugu S. Cephalometric abnormalities in non-obese and obese patients with obstructive sleep apnoea. Eur. Respir. J. 1999;13: 403-410.
68. Dancey D.R., Hanly P.J., Soong C., Lee B., Hoffstein V. Impact of menopause on the prevalence and severity of sleep apnea. Chest 2001; 120: 151-155.
69. Eichling P.S., Sahni J. Menopause related sleep disorders. J. Clin. Sleep Med. 2005; 15: 291-300.
70. Russell T., Duntley S. Sleep disordered breathing in the elderly. Am. J. Med. 2011; 12: 1123-1126.
71. Jennum P., Riha R.L. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur. Respir. J. 2009; 33: 907-914.
72. Norman D., Loredo J.S. Obstructive sleep apnea in older adults. Clin. Geriatr. Med. 2008; 24: 151-165.
73. Guilleminault C., Partinen M., Hollman K., Powell N., Stoohs R. Familiar aggregates in obstructive sleep apnea syndrome. Chest 1995; 107: 1545-1551.
74. Kaparianos A., Sampsonas F., Karkoulias K., Spiropoulos K. Obstructive sleep apnoea syndrome and genes. Neth. J. Med. 2006; 64: 280-289.
75. Polotsky V.Y., O'Donnell C.P. Genomics of sleep-disordered breathing. Proc. Am. Thorac. Soc. 2007; 4: 121-126.
76. Campana L., Eckert D.J., Patel S.R., Malhotra A. Pathophysiology & genetics of obstructive sleep apnoea. Indian. J. Med. Res. 2010; 131: 176-187.
77. Resta O., Pannacciulli N., Di Gioia G., Stefàno A., Barbaro M.P., De Pergola G. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr. Metab. Cardiovasc. Dis. 2004;14: 248-253.
78. Weiss V., Sonka K., Pretl M. i wsp. Prevalence of the sleep apnea syndrome in acromegaly population. J. Endocrinol. Invest. 2000; 23: 515-519.
79. Ferber R., Millman R., Coppola M. i wsp. Portable recording in the assessment of obstructive sleep apnea. ASDA standards of practice. Sleep. 1994; 17: 378-392.
80. Chesson A.L. Jr., Berry R.B., Pack A.; American Academy of Sleep Medicine; American Thoracic Society; American College of Chest Physicians. Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 2003; 26: 907-913.
81. Iber C., Ancoli-Israel S., Chesson A.L., Quan S.F.; for the American Academy of Sleep Medicine: The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. American Academy of Sleep Medicine, Westchester, IL, 2007.
82. Rechtschaffen A., Kales A. A manual of standarized terminology, techniques and scoring system for sleep stages of human subjects. UCLA Brain Information Service/ Brain Research Institute. Los Angeles 1968.
83. Chokroverty S., Bhatt M., Thomas R.J. (red.). Atlas of Sleep Medicine, Elsevier, Philadelphia, 2005.
84. George Ch.F.P. Standards for polysomnography in Canada. Can. Med. Assoc. J. 1996; 12: 1673-1678.
85. Guilleminault C. (red.). Sleep and waking disorders - indications and techniques. Addison-Wenley, Menlo Park-California, 1982.
86. Kushida C.A., Littner M.R., Morgenthaler T. i wsp. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005; 28: 499-521.
87. Shneerson J.M. (red.). Sleep medicine: a guide to sleep and its disorders. Blackwell Publishing, Malden, 2005.
88. Ferber R.T. (red.). Progress in sleep apnea research. Nova Science Publishers, New York, 2007.
89. Kushida C.A., Chediak A., Berry R.B. i wsp. Positive Airway Pressure Titration Task Force; American Academy of Sleep Medicine. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J. Clin. Sleep Med. 2008; 4: 157-171.
90. Silber M.H., Ancoli-Israel S., Bonnet M.H. i wsp. The visual scoring of sleep in adults. Clin. Sleep Med. 2007; 3: 121-131.
91. Thomas R.J. Cyclic alternating pattern and positive airway pressure titration. Sleep Med. 2002; 3: 315-322.
92. Collop N.A., Anderson W.M., Boehlecke B., i wsp. Portable Monitoring Task Force of the American Academy of Sleep Medicine. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J. Clin. Sleep Med. 2007; 3: 737-747.
93. Ohayon M.M. From wakefulness to excessive sleepiness: what we know and still need to know. Sleep Med. Rev. 2008; 12: 129-141.
94. Schweizer P.K. Drugs that disturb sleep and wakefulness. W: Kryger M.H., Roth T., Dement D.D. (red.). Principles and practice of sleep medicine. 4th edition. Philadelphia, Elsevier 2005: 499-518.
95. Carskadon M.A., Dement W.C., Mitler M.M., Roth T., Westbrook P.R., Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986; 9: 519-524.
96. Thorpy M.J. The clinical use of the Multiple Sleep Latency Test. The Standards of Practice Committee of the American Sleep Disorders Association. Sleep 1992; 15: 268-276.
97. Mitler M.M., Gujavarty K.S., Browman C.P. Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence. Electroencephalogr. Clin. Neurophysiol. 1982; 53: 658-661.
98. McNicholoas W.T, Bonsignore M.R.; and the Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur. Respir. J. 2007; 29: 156-178.
99. Robinson G.V., Stradling J.R., Davies R.J. Sleep. 6: Obstructive sleep apnoea/hypopnoea syndrome and hypertension. Thorax 2004; 59: 1089-1094.
100. Dart R.A., Gregoire J.R., Gutterman D.D., Woolf S.H. The association of hypertension and secondary cardiovascular disease with sleep disordered breathing. Chest 2003; 123: 44-260.
101. Baguet J., Hammer L., Levy P. i wsp. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J. Hypertens. 2005; 23: 521-527.
102. Planes C., Leroy M., Payet G., Aegerter P., Poucher A., Raffestin B. Exacerbation of sleep-apnoea related nocturnal blood pressure fluctuations in hypertensive subjects. Eur. Respir. J. 2002: 20: 151-157.
103. Peker Y., Hedner J., Kraiczi H. Loth S. Respiratory disturbance index: an independent predictor of mortalityin coronary artery disease. Am. J. Respir. Crit. Care Med. 2000; 162: 81-86.
104. Hug J., Whitford E.G., Parsons R.W., Hillman D.R. Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336: 261-264.
105. D'Alessandro R., Magelli C., Gamberini G. i wsp. Snoring every night as a risk factor for myocardial infarction: a case-control study. BMJ 1990; 300: 1557-1558.
106. Shamsuzzaman A.S., Gersh B.J., Somers V.K. Obstructive sleep apnea. Implication for cardiac and vascular disease. JAMA 2003, 290, 14: 1906-1914.
107. Somers V.K. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J. Am. Col. Cardiol. 2008; 52: 686-717.
108. Tazbirek M., Słowińska L., Skoczyński S., Pierzchała W. Short term continuous positive airway pressure (CPAP) therapy reverses the pathological influence of obstructive sleep apnea (OSA) on blood rheology. Clin. Hemorheol. Microcrc. 2009; 41; 241-249.
109. Główczyńska R., Kukwa W., Opolski G. Choroby serca - powikłania u chorych na OBPS. Pneumonol. Alergol. Pol. 2007; 75 (supl. 1): 50-56.
110. Boguet J.P., Hammer L., Levy P. i wsp. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 2005; 128: 3407-3412.
111. Suzuki T., Nakano H., Maekawa J. i wsp. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 2004; 27: 129-133.
112. Peker Y., Carlson J., Hedner J. Increased incidence of coronary artery disease in sleep apnoea: long-term follow-up. Eur. Respir. J. 2006; 28: 596-602.
113. Wessendorf T.E., Thilmann A.F., Wang Y.M. i wsp. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am. J. Respir. Crit. Care Med. 2000; 162: 2039-2042.
114. Nobili L., Schiavi G., Bozano E. i wsp. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin. Hemorheol. Microcrc. 2000; 22; 21-27.
115. Yaggi H., Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol. 2004; 3: 333-342.
116. Arzt M., Young T., Finn L., Skatrud J.B., Bradley T.D. Association of sleep-disordered breathing and the occurrence of stroke. Am. J. Respir. Crit. Care Med. 2005; 172: 1447-1451.
117. Yaggi H.K., Concanto J., Kernan N.W. i wsp. Obstructive sleep apnea as a risk factor for stroke and death. N. Eng. J. Med. 2005; 19: 2034-2042.
118. Parra O., Arboix A., Montserrat J.M., Quinto L., Bechich S., Garcia-Eroles L. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur. Respir. J. 2004; 24: 267-272.
119. Martinez-Garcia M.A, Galiano-Blancart R., Roman-Sanchez P., Soler-Cataluna J.J., Cabero-Salt L., Salcedo-Maiques E. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 2005; 128: 2123-2129.
120. Para O., Arboix A., Bechich S. i wsp. Time course of sleep related breathing disordered in first-ever stroke or transient ischemic attack. Am. J. Respir. Crit. Care Med. 2000; 161: 375-380.
121. Łabuz-Roszak B., Tazbirek M., Pierzchała K., Pierzchała W. Ocena cze{ogonek}stości wyste{ogonek}powania zespołu bezdechu we śnie u chorych we wczesnej fazie udaru mózgu. Pol. Merk. Lek. 2004; 96: 536-538.
122. Dziewas R., Humpert M., Hopmann B. i wsp. Increased prevelence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims. J. Neurol. 2005; 252: 2123-2129.
123. Kaneko Y., Hajek V.E., Zivanovic V., Raboud J., Bradley T.D. Relationship of sleep apnea to functional capacity and lenth of hospitalization following stroke. Sleep 2003; 26: 293-297.
124. Shepard J.W., Garrison M.W., Grither D.A., Dolan G.F. Relationship of ventricular ectopy to oxyhemoglobin desaturaton in patients with obstructive sleep apnea. Chest 1985; 88: 335-340.
125. Mehra R., Benjamin E.J., Shahar E. i wsp. Association of nocturnal arrhytmias with sleep-disordered breathing: the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2006; 173: 910-916.
126. Gami A.S., Pressman G., Caples S.M. i wsp. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110: 364-367.
127. Shahar E., Whitney C.W., Redline S. i wsp. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2001; 163: 19-25.
128. Sin D.D., Fitzgerald F., Parker J.D., Newton G., Floras J.S., Bradley T.D. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am. J. Respir. Crit. Care Med. 1999; 160: 1101-1106.
129. Javaheri S., Parker T.J., Liming J.D. i wsp. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-2159.
130. Malone S., Liu P.P., Holloway R., Rutherford R., Xie A., Bradley T.D. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338: 1480-1484.
131. Kaneko Y., Floras J.S., Usui K. i wsp. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N. Engl. J. Med. 2003; 348: 1233-1241.
132. Mansfield D.R., Gollogly N.C., Kaye D.M., Richardson M., Bergin P., Naughton M.T. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am. J. Respir. Crit. Care Med. 2004; 169: 361-366.
133. Wang H., Parker J.D., Newton G.E. i wsp. Influence of obstructive sleep apnea on mortality in patients with heart failure. J. Am. Coll. Cardiol. 2007; 49: 1625-1631.
134. Chaouat A., Weitzeblum E., Krieger J., Oswald M., Kessler R. Pulmonary hemodynamics in obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996; 109: 380-386.
135. Punjabi N.M., Shahar E., Redline S., Gottlieb D.J., Givelber R., Resnick H.E.; Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol. 2004; 160: 521-530.
136. Reichmuth K.J., Austin D., Skatrud J.B., Young T. Association of sleep apnea and type II diabetes: a population-based study. Am. J. Respir. Crit. Care Med. 2005; 17: 1590-1595.
137. Botros N., Concato J., Mohsenin V., Selim B., Doctor K., Yaggi H.K. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am. J. Med. 2009; 122: 1122-1127.
138. Muraki I., Tanigawa T., Yamagishi K. i wsp. Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia 2010; 53: 481-488.
139. Lam J.C., Lam B., Yao T.J. i wsp. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur. Respir. J. 2010; 35: 138-145.
140. West S.D., Nicoll D.J., Wallace T.M., Matthews D.R., Stradling J.R. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007; 62: 969-974.
141. Coughlin S.R., Mawdsley L., Mugarza J.A., Wilding J.P., Calverley P.M. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur. Respir. J. 2007; 29: 720-727.
142. Clarenbach C.F., West S.D., Kohler M. Is obstructive sleep apnea a risk factor for diabetes? Discov. Med. 2011; 12: 17-24.
143. Zanation A.M., Senior B.A. The relationship between extraesophageal reflux (EER) and obstructive sleep apnea (OSA). Sleep Med. Rev. 2005; 9: 453-458.
144. DeCary A., Rouleau I., Montplaisir J.J. Congenitive deficits associayed with sleep apnea syndrome: a proposed neuropsychological test battery. Sleep 2000; 23: 369-381.
145. Borak J., Ciesielski J.K., Koziej M., Matuszewski A., Zieliński J. Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J. Sleep Res. 1996; 5: 123-127.
146. Kalina M., Jurek-Pelczarska J., Koślacz E., Farnik M., Tazbirek M. Poziom depresji u osób z zespołem obturacyjnego bezdechu w czasie snu (doniesienie wste{ogonek}pne). Wiad. Lek. 1999; 52: 134-143.
147. Sforza E., de Saint Hilaire Z., Pelissolo A., Rochat T., Ibanez V. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: Effects of reduced daytime alertness. Sleep Med. 2002; 3: 139-145.
148. Lopes C., Esteves A.M., Bittencourt L.R., Tufik S., Mello M.T. Relationship between the quality of life and the severity of obstructive sleep apnea syndrome. Braz. J. Med. Biol. Res. 2008; 41: 908-913.
149. Tregear S., Reston J., Schoelles K., Phillips B. Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis. J. Clin. Sleep Med. 2009; 15: 573-581.
150. Young T., Finn L., Peppard P.E. i wsp. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008; 31: 1071-1078.
151. Marshall N.S., Wong K.K., Liu P.Y., Cullen S.R., Knuiman M.W., Grunstein R.R. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008; 31: 1079-1085.
152. Lugaresi E., Cirignotta F., Gererdi R., Montagna P. Snoring and sleep apnea: natural history of heavy snorers disease. W: Guilleminault C, Partinen M. (red.). Obstructive sleep apnea: clinical research and treatment. Raven Press, New York 1990; 25-36.
153. Koenig J.S., Thach B.T. Effects of mass loading on the upper airway. J. Appl. Physiol. 1988; 64: 2294-2299.
154. Browman C.P, Sampson M.G, Yolles S.F i wsp. Obstructive sleep apnea and body weight. Chest 1984; 85: 435-438.
155. Peppard P.E., Young T., Palta M. i wsp. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015-3021.
156. Smith P.L, Gold A.R, Meyers D.A, Haponik E.F, Bleecker E.R. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann. Intern. Med. 1983; 103: 850-855.
157. Cartwright R.D. Effect of position on sleep apnea severity. Sleep 1984; 7: 110-114.
158. George C.F., Millar T.W., Kryger M.H. Sleep apnea and body position during sleep. Sleep 1988; 11: 90-99.
159. Berry R.B., Bonnet M.H., Light R.W. Effect of ethanol on the arousal response to airway occlusion during sleep in normal subjects. Am. Rev. Respir. Dis. 1992; 145: 445-452.
160. Issa F.G., Sullivan C.E. Alcohol, snoring and sleep apnea. J. Neurol. Neurosurg. Psychiatry 1982; 45: 353-359.
161. Berry R.T., Desa M.M., Light R.W. Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment of obstructive sleep apnea. Chest 1991; 99: 339-343.
162. Wetter D.W., Young T.B., Bidwell T.R. i wsp. Smoking as a risk factor for sleep-disordered breathing. Arch. Intern. Med. 1994; 154: 2219-2224.
163. Hoflstein V. Relationship between smoking and sleep apnea in clinic population. Sleep 2002; 25: 519-524.
164. Dolly F.R., Block A.J. Effect of flurazepam on sleep-disordered breathing and nocturnal desaturation in asymptomatic subjects. Am. J. Med. 1982; 73: 239-243.
165. Hedemark L.L., Kronenberg R.S. Flurazepam attenuates the arousal response to sleep in normal subjects. Am. Rev. Respir. Dis. 1983; 128: 980-983.
166. Boushra N.N. Anesthetic management of patients with sleep apnea syndrome. Can. J. Anaesth. 1996; 43: 599-616.
167. Ono T., Lowe A.A., Ferguson K.A., Pae E.K., Fleetham J.A. A tongue retaining device and sleep-state genioglossus muscle activity in patients with obstructive sleep apnea. Angle Orthod. 1996; 66: 273-280.
168. Gao X.M., Zeng X.L., Fu M.K., Huang X.Z. Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after oral appliance therapy. Chin. J. Dent. Res. 1999; 2: 27-35.
169. Mehta A., Qian J., Petocz P., Darendeliler M.A., Cistulli P.A. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2001; 163: 1457-1461.
170. Hans M.G., Nelson S., Luks V.G., Lorkovich P., Baek S.J. Comparison of two dental devices for treatment of obstructive sleep apnea syndrome (OSAS). Am. J. Orthod. Dentofacial. Orthop. 1997; 111: 562-570.
171. Ferguson K.A., Ono T., Lowe A.A., Keenan S.P., Fleetham J.A. A randomized crossover study of an oral appliance vs. nasalcontinuous positive airway pressure in the treatment of mild- -moderate obstructive sleep apnea. Chest 1996; 109: 1269-1275.
172. Korczyński P., Górska K., Wilk K., Bielicki P., Byśkiniewicz K., Baczkowski T. Mandibular advancement devices in the treatment of obstructive sleep apnea. Pol. Mekur. Lek. 2004; 17: 597-599.
173. Johnston C.D., Gleadhill I.C., Cinnamond M.J., Peden W.M. Oral appliances for the management of severe snoring: a randomized controlled trial. Eur. J. Orthod. 2001; 23: 127-134.
174. Sullivan C.E., Issa F.G., Berthon-Jones M., Eves L. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1981; 8225: 862-865.
175. Monasterio C., Vidal S., Duran J. i wsp. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am. J. Repir. Crit. Care Med. 2001; 164: 939-943.
176. Barbe F., Mayoralas L.R., Duran J. i wsp. Treatment with continuosus positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. Ann. Intern. Med. 2001; 134: 1065-1067.
177. Morgenthaler T.I., Aurora R.N., Brown T. i wsp. Standards of Practice Committee of the AASM; American Academy of Sleep Medicine. Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine report. Sleep 2008; 1: 141-147.
178. Randerath W.J., Verbraecken J., Andreas S. i wsp. the European Respiratory Society task force on non-CPAP therapies in sleep apnoea. ERS TASK FORCE REPORT. Non-CPAP therapies in obstructive sleep. Eur. Respir. J. 2011; 37: 1000-1028.
179. Aurora R.N., Casey K.R., Kristo D. i wsp. Practice Parameters for the Surgical Modifications of the Upper Airway for Obstructive Sleep Apnea in Adults. Sleep 2010; 33: 1408-1413.
180. Buchwald H., Avidor Y., Braunwald E. i wsp. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
181. Greenburg D.L., Lettieri C.J., Eliasson A.H. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta- -analysis. Am. J. Med. 2009; 122: 535-542.
182. Anholm J.D., Powles A.C., Downey R. 3rd i wsp. Operation Everest II: arterial oxygen saturation and sleep at extreme simulated altitude. Am. Rev. Respir. Dis. 1992; 145: 817-826.
183. Lahiri S., Barnard P. Role of arterial chemoreflex in breathing during sleep at high altitude. Prog. Clin. Biol. Res. 1983; 136: 75-85.
184. Farney R.J., Walker J.M., Cloward T.V., Rhondeau S. Sleep-disordered breathing associated with long-term opioid therapy. Chest 2003; 123: 632-639.
185. Franklin K.A., Eriksson P., Sahlin C. i wsp. Reversal of central sleep apnea with oxygen. Chest 1997; 111: 163-169.
186. Javaheri S., Ahmed M., Parker T.J., i wsp. Effects of nasal O2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999; 22: 1101-1106.
187. Steens R.D., Millar T.W., Su X. i wsp. Effects of inhaled 3% CO2 on Cheyne-Stokes respiration in congestive heart failure. Sleep 1994; 17: 61-68.
188. Szollosi I., Jones M., Morrrell M.J. i wsp. Effects of CO2 inhalation on central sleep apnea and arousals from sleep. Respiration 2004; 71: 493-498.
189. Krachman S.L., Crocetti J., Berger T.J. i wsp. Effects of nasal continuous positive airway pressure on oxygen body stores in patients with Cheeyne-Stokes respiration and congestive heart failure. Chest 2003; 123: 59-66.
190. Arzt M., Bradley T.D. Treatment of sleep apnea in heart failure. Am. J. Respir. Crit. Care Med. 2006; 173: 1300-1308.
191. Bradley T.D., Logan A.G., Kimoff R.J. i wsp. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 2005; 353: 2025-2033.
192. Philippe C., Stoica-Herman M., Drouot X., i wsp. Compliance with and effectiveness of adaptive servoventilation versus con tinuous positive airway pressure in the treatment of Cheyne- -Stokes respiration in heart failure over a six month period. Heart 2006; 92: 337-342.
193. Pepperell J.C., Maskell N.A., Jones D.R. i wsp. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am. J. Respir. Crit. Care Med. 2003; 168: 1109-1114.
194. Fleetham J., Ayas N., Bradley D. i wsp. Canadian Thoracic Society Sleep Disordered Breathing Committee. Canadian Thoracic Society 2011 guideline update: diagnosis and treatment of sleep disordered breathing. Can. Respir. J. 2011; 18: 25-47.
195. Solin P., Bergin P., Richardson M. i wsp. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999; 99: 1574-1579.
196. Mansfield D.R., Solin P., Roebuck T. i wsp. The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest 2003; 124: 1675-1681.
197. White D.P., Zwillich C.W., Piickett C.K. i wsp. Central sleep apnea: iimprovement with acetazolamide therapy. Arch. Intern. Med. 1982; 142: 1816-1819.
198. Nakayama H., Smith C.A., Rodman J.R. i wsp. Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am. J. Respir. Crit. Care Med. 2002; 165: 1251-1260.
199. Gilmartin G.S., Daly R.W., Thomas R.J. Recognition and management of complex sleep disordered breathing. Curr. Opin. Pulm. Med. 2005; 11: 485-93.
200. Flenley D.C. Sleep in chronic obstructive lung disease. Clin. Chest Med. 1985; 6: 51-61.
201. Bednarek M., Pływaczewski R., Jonczak L., Zieliński J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 2005; 72: 142-149.
202. Weitzenblum E., Kessler R., Canuet M., Chaouat A. Obesity- -hypoventilation syndrome. Rev. Mal. Respir. 2008; 25: 391-403.
203. Sanders M.H., Montserrat J.M., Farré R., Givelber R.J. Positive pressure therapy: a perspective on evidence-based outcomes and methods of application. Proc. Am. Thorac. Soc. 2008; 5: 161-172.
204. Sanders M.H., Newman A.B., Haggerty C.L. i wsp. Sleep Heart Health Study. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am. J. Respir. Crit. Care Med. 2003; 167: 7-14.
205. Chaouat A., Weitzenblum E., Krieger J., Ifoundza T., Oswald M., Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am. Rev. Respir. Dis. 1995; 151: 82-86.
206. Casey K.R., Cantillo K.O., Brown L.K. Sleep-related hypoventilation/ hypoxemic syndromes. Chest 2007; 131: 1936-1948.
207. Fletcher E.C., Shah A., Qian W., Miller C.C. 3rd "Near miss" death in obstructive sleep apnea: a critical care syndrome. Crit. Care. Med. 1991; 19: 1158-1164.
208. Ashutosh K., Mead G., Dunsky M. Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale. Am. Rev. Respir. Dis. 1983; 127: 399-404.
209. Brzecka A., Piesiak P., Kosacka M., Kasibowska-Kuźniar K., Jankowska R. Wyniki leczenia zaburzeń oddechowych w czasie snu metoda{ogonek} cia{ogonek}głego dodatniego ciśnienia w drogach oddechowych u chorych z zespołem obturacyjnego bezdechu śródsennego ze współistnieja{ogonek}ca{ogonek} przewlekła{ogonek} obturacyjna{ogonek} choroba{ogonek} płuc. Adv. Clin. Exp. Med. 2005; 14: 2B, 43-49.
210. Kessler R., Chaouat A., Weitzenblum E. i wsp. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur. Respiro. J. 1996; 9: 787-794.
211. Brzecka A. Wpływ przewlekłej niewydolności oddechowej na wyniki leczenia chorych z zespołem obturacyjnego bezdechu śródsennego metoda{ogonek} dwufazowego ciśnienia dodatniego w drogach oddechowych (BiPAP). Adv. Clin. Exp. Med. 2002; 11: 313-318.
212. Gay P., Weaver T., Loube D., Iber C.; Positive Airway Pressure Task Force; Standards of Practice Committee; American Academy of Sleep Medicine. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 2006; 29: 381-401.
213. Lee W.Y., Mokhlesi B. Diagnosis and management of obesity hypoventilation syndrome in the ICU. Crit. Care Clin. 2008; 24: 533-549.
214. Mokhlesi B., Tulaimat A., Faibussowitsch I., Wang Y., Evans A.T. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007; 11: 117-124.
215. Olson A.L., Zwillich C. The obesity-hypoventilation syndrome. Am. J. Med. 2005; 118: 948-956.
216. Kessler R., Chaouat A., Schinkewitch Ph. i wsp. The obesity- -hypoventilation syndrome revisited. A prospective study of 34 consecutive cases. Chest 2001; 120: 369-376.
217. Pérez de Llano L.A., Golpe R., Ortiz Piquer M. i wsp. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005; 128: 587-594.
218. Verin E., Tardif C., Pasquis P. Prevalence of daytime hypercapnia or hypoxia in patients with OSAS and normal lung function. Respir. Med. 2001; 95, 693-696.
219. Mokhlesi B., Kryger M.H., Grunstein R.R. Assessment and management of patients with obesity hypoventilation syndrome. Proc. Am. Thorac. Soc. 2008; 5: 218-225.
220. Nowbar S., Burkart K.M., Gonzales R. i wsp. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am. J. Med. 2004; 116: 1-7.
221. Berger K.I., Ayappa I., Chatr-Amontri B. i wsp. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest 2001; 120: 1231-1238.
222. Mokhlesi B., Tulaimat A., Evans A.T. i wsp. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. Sleep Med. 2006; 2: 57-62.
223. Sugerman H.J., Baron P.L., Fairman R.P., Evans C.R., Vetrovec G.W. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann. Surg. 1988; 207: 604-613.
224. Shivaram U., Cash M.E., Beal A. Nasal continuous positive airway pressure in decompensated hypercapnic respiratory failure as a complication of sleep apnea. Chest 1993, 104, 770-774.
225. Sullivan C.E., Berthon-Jones M., Issa F.G. Remission of severe obesity-hypoventilation syndrome after short-term treatment during sleep with nasal continuous positive airway pressure. Am. Rev. Respir. Dis. 1983; 128: 177-181.
226. Budweiser S., Hitzl A.P., Jörres R.A., Schmidbauer K., Heinemann F., Pfeifer M. Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis. Respir. Res. 2007; 17: 92-101.
227. Masa J.F., Celli B.R., Riesco J.A., Hernández M., Sánchez De Cos J., Disdier C. The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest 2001; 119: 1102-1107.
228. Piper A.J., Sullivan C.E. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994; 105: 434-440.
229. Storre J.H., Seuthe B., Fiechter R. i wsp. Average volume-assured pressure support in obesity hypoventilation: A randomized crossover trial. Chest 2006; 130: 815-821.
230. Waldhorn R.E. Nocturnal nasal intermittent positive pressure ventilation with bi-level positive airway pressure (BiPAP) in respiratory failure. Chest 1992; 101: 516-521.
231. Heinemann F., Budweiser S., Dobroschke J., Pfeifer M. Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir. Med. 2007; 101: 1229-1235.
232. Guo Y.F., Sforza E., Janssens J.P. Respiratory patterns during sleep in obesity-hypoventilation patients treated with nocturnal pressure support: a preliminary report. Chest 2007; 131: 1090-1099.
233. Schönhofer B., Sonneborn M., Haidl P., Böhrer H., Köhler D. Comparison of two different modes for noninvasive mechanical ventilation in chronic respiratory failure: volume versus pressure controlled device. Eur. Respir. J. 1997; 10, 184-191.
234. Thomas R.J. Therapy and PSG: Continuous positive airway pressure and bilevel positive airway pressure. W: Chokroverty S., Bhatt M., Thomas R.J. (red.). Atlas of Sleep Medicine, Elsevier, Philadelphia 2005: 289-324.
235. Sugerman H.J., Fairman R.P., Sood R.K., Engle K., Wolfe L., Kellum J.M. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am. J. Clin. Nutr. 1992; 55 (2 supl.): 597S-601S.
236. Verse T. Bariatric surgery for obstructive sleep apnea. Chest 2005; 128: 485-487.
237. Fischer J., Dogas Z., Bassetti C.L. i wsp.; Executive Committee (EC) of the Assembly of the National Sleep Societies (ANSS); Board of the European Sleep Research Society (ESRS), Regensburg, Germany. Standard procedures for adults in accredited sleep medicine centres in Europe. J. Sleep Res. 2012; 21: 357-368.
238. ESRS task force: Pevernagie D., Stanley N., Berg S. i wsp. European guidelines for the certification of professionals in sleep medicine: report of task force of European Sleep Research Society. J. Sleep Res., 2009; 18: 136-141.
239. European Sleep Research Society, European guidelines for the accreditation of Sleep Medicine Centres. J. Sleep Res., 2006; 15: 231-238.